Cargando…
Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
BACKGROUND/OBJECTIVE: Reducing severity of Cushing’s syndrome caused by an adrenal adenoma (adrenal Cushing’s syndrome [ACS]) might decrease morbidity and mortality risk in adrenalectomy. We used off-label osilodrostat, approved in the United States for pituitary Cushing’s disease, to reduce cortiso...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Clinical Endocrinology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701912/ https://www.ncbi.nlm.nih.gov/pubmed/36447826 http://dx.doi.org/10.1016/j.aace.2022.10.001 |